279 related articles for article (PubMed ID: 19178698)
1. From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases.
Zakrzewicz D; Eickelberg O
BMC Pulm Med; 2009 Jan; 9():5. PubMed ID: 19178698
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
3. Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA.
Bulau P; Zakrzewicz D; Kitowska K; Leiper J; Gunther A; Grimminger F; Eickelberg O
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L18-24. PubMed ID: 16891395
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
Davids M; Teerlink T
Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
[TBL] [Abstract][Full Text] [Related]
5. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
6. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.
Tojo A; Welch WJ; Bremer V; Kimoto M; Kimura K; Omata M; Ogawa T; Vallance P; Wilcox CS
Kidney Int; 1997 Dec; 52(6):1593-601. PubMed ID: 9407505
[TBL] [Abstract][Full Text] [Related]
7. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
[TBL] [Abstract][Full Text] [Related]
8. Pan-methylarginine antibody generation using PEG linked GAR motifs as antigens.
Wang Y; Person MD; Bedford MT
Methods; 2022 Apr; 200():80-86. PubMed ID: 34107353
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy.
Bełtowski J; Kedra A
Pharmacol Rep; 2006; 58(2):159-78. PubMed ID: 16702618
[TBL] [Abstract][Full Text] [Related]
10. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition.
Servillo L; Giovane A; Cautela D; Castaldo D; Balestrieri ML
Nitric Oxide; 2013 Apr; 30():43-8. PubMed ID: 23438481
[TBL] [Abstract][Full Text] [Related]
11. GC-MS and LC-MS/MS pilot studies on the guanidine (N
Bollenbach A; Gambaryan S; Mindukshev I; Pich A; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122024. PubMed ID: 32062367
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
Böger RH; Bode-Böger SM
Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
[TBL] [Abstract][Full Text] [Related]
13. Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production.
Pope AJ; Karuppiah K; Cardounel AJ
Pharmacol Res; 2009 Dec; 60(6):461-5. PubMed ID: 19682581
[TBL] [Abstract][Full Text] [Related]
14. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.
Milewski K; Bogacińska-Karaś M; Fręśko I; Hilgier W; Jaźwiec R; Albrecht J; Zielińska M
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099056
[TBL] [Abstract][Full Text] [Related]
15. PRMT-5 converts monomethylarginines into symmetrical dimethylarginines in Caenorhabditis elegans.
Kanou A; Kako K; Hirota K; Fukamizu A
J Biochem; 2017 Feb; 161(2):231-235. PubMed ID: 28173048
[TBL] [Abstract][Full Text] [Related]
16. [Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase].
Masuda H; Azuma H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):29-35. PubMed ID: 11862754
[TBL] [Abstract][Full Text] [Related]
17. Whole-body arginine dimethylation is associated with all-cause mortality in adult renal transplant recipients.
Post A; Bollenbach A; Bakker SJL; Tsikas D
Amino Acids; 2021 Apr; 53(4):541-554. PubMed ID: 33651245
[TBL] [Abstract][Full Text] [Related]
18. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
19. The Second Life of Methylarginines as Cardiovascular Targets.
Jarzebska N; Mangoni AA; Martens-Lobenhoffer J; Bode-Böger SM; Rodionov RN
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533264
[TBL] [Abstract][Full Text] [Related]
20. ADMA metabolism and clearance.
Teerlink T
Vasc Med; 2005 Jul; 10 Suppl 1():S73-81. PubMed ID: 16444872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]